Limited alignment of publicly competitive disease funding with disease burden in Japan

Nomura, Shuhei; Yoneoka, Daisuke; Tanaka, Shiori; Makuuchi, Ryoko; Sakamoto, Haruka; Ishizuka, Aya; Nakamura, Haruyo; Kubota, Anna; Shibuya, Kenji

doi:10.1371/journal.pone.0228542

Cited by 1 publication

(2 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This calls for greater management over the allocation of scarce resources for health research and action. 37 In Japan, smoking has a great influence on the population's health. While there is solid scientific evidence of its harmful effects, as of 2019 approximately 26% of men and 7% of women still smoke daily.…”

Section: More Public Health Efforts Are Needed To Address Critical Risk Factors For the Rising Burden Of Ncdsmentioning

confidence: 99%

See 1 more Smart Citation

Toward a third term of Health Japan 21 – implications from the rise in non-communicable disease burden and highly preventable risk factors

Nomura

Sakamoto

Ghaznavi

et al. 2022

The Lancet Regional Health - Western Pacific

Self Cite

View full text Add to dashboard Cite

In 2000, the Japanese government launched the National Health Promotion Movement known as Health Japan 21 (HJ21), a 13-year national health promotion policy (2000−2012) aimed at preventing and controlling non-communicable diseases (NCDs) and their underlying risk factors. After the revision in 2013 (2013−2023), the target NCDs and risk factors are being reviewed and a new strategy for the third term of HJ21 is going to be discussed. Using the latest findings from the Global Burden of Disease Study 2019, this paper highlights NCDs that continue to increase health losses and preventable metabolic and behavioural risk factors. These NCDs and risk factors are associated with an increased risk of serious illness and death from the novel coronavirus disease (COVID-19). The third term of HJ21 will be formulated during the continuing threat of acute health crises like the current COVID-19 pandemic and thus offers an important opportunity to renew public health efforts to halt the growing burden of NCDs in Japan. This article may serve as one of the roadmaps for the formulation of the third term of HJ21.

show abstract

Section: More Public Health Efforts Are Needed To Address Critical Risk Factors For the Rising Burden Of Ncdsmentioning

confidence: 99%

“…This calls for greater management over the allocation of scarce resources for health research and action. 37 …”

Section: More Public Health Efforts Are Needed To Address Critical Ri...mentioning

confidence: 99%

Toward a third term of Health Japan 21 – implications from the rise in non-communicable disease burden and highly preventable risk factors

Nomura

Sakamoto

Ghaznavi

et al. 2022

The Lancet Regional Health - Western Pacific

Self Cite

View full text Add to dashboard Cite

show abstract

Limited alignment of publicly competitive disease funding with disease burden in Japan

Abstract: ObjectiveThe need to align investments in health research and development (R&D) with public health needs is one of the most important public health challenges in Japan. We examined the alignment of disease-specific publicly competitive R&D funding to the disease burden in the country.

Cited by 1 publication

References 35 publications

Toward a third term of Health Japan 21 – implications from the rise in non-communicable disease burden and highly preventable risk factors

Toward a third term of Health Japan 21 – implications from the rise in non-communicable disease burden and highly preventable risk factors

Contact Info

Product

Resources

About